Novel phenylpiperazine derivatives as dual cytokine regulators with TNF-alpha suppressing and IL-10 augmenting activity

The structures of eleven (4-phen-yl)piperazinium salts containing organic anions

Eleven (4-phen-yl)piperazinium salts containing organic anions have been prepared and structurally characterized, namely, 4-phenyl-piperazin-1-ium 4-fluoro-benzoate monohydrate, C10H15N2 +·C7H4FO2 -·H2O, 1; 4-phenyl-piperazin-1-ium 4-bromo-benzoate monohydrate, C10H15N2 +·C7H4BrO2 -·H2O, 3; 4-phenyl-piperazin-1-ium 4-iodo-benzoate, C10H15N2 +·C7H4IO2 -, 4; 4-phenyl-piperazin-1-ium 4-nitro-benzoate, C10H15N2 +·C7H4NO4 -, 5; 4-phenyl-piperazin-1-ium 3,5-di-nitro-salicylate, C10H15N2 +·C7H3N2O7 -, 6; 4-phenyl-piperazin-1-ium 3,5-di-nitro-benzoate, C10H15N2 +·C7H3N2O6 -, 7; 4-phenyl-piperazin-1-ium picrate, C10H15N2 +·C6H2N3O7 -, 8; 4-phenyl-piperazin-1-ium benzoate monohydrate, C10H15N2 +·C7H5O2 -·H2O, 9; 4-phenyl-piperazin-1-ium p-toluene-sulfonate, C10H15N2 +·C7H7O3S-, 10; 4-phenyl-piperazin-1-ium tartarate monohydrate, C10H15N2 +·C4H5O6 -·H2O, 11; and 4-phenyl-piperazin-1-ium fumarate, C10H15N2 +·C4H3O4 -, 12. Compounds 1 and 3-12 are all 1:1 salts with the acid proton transferred to the phenyl-piperaizine basic N atom (the secondary amine) with the exception of 3 where there is disorder in the proton position with it being 68% attached to the base and 32% attached to the acid. Of the structures with similar stoichiometries only 3 and 9 are isomorphous. The 4-phenyl substituent in all cases occupies an equatorial position except for 12 where it is in an axial position. The crystal chosen for structure 7 was refined as a non-merohedral twin. There is disorder in 5, 6, 10 and 11. For both 5 and 6, a nitro group is disordered and was modeled with two equivalent orientations with occupancies of 0.62 (3)/0.38 (3) and 0.690 (11)/0.310 (11), respectively. For 6, 10 and 11, this disorder is associated with the phenyl ring of the phenyl-piperazinium cation with occupancies of 0.687 (10)/0.313 (10), 0.51 (7)/0.49 (7) and 0.611 (13)/389 (13), respectively. For all salts, the packing is dominated by the N-H⋯O hydrogen bonds formed by the cation and anion. In addition, several structures contain C-H⋯π (1, 3, 4, 8, 9, 10, and 12) and aromatic π-π stacking inter-actions (6 and 8) and one structure (5) contains a -NO2⋯π inter-action. For all structures, the Hirshfeld surface fingerprint plots show the expected prominent spikes as a result of the N-H⋯O and O-H⋯O hydrogen bonds.

Synthesis and crystal structures of 1-benzoyl-4-(4-nitro-phen-yl)piperazine and 1-(4-bromo-benzo-yl)-4-phenyl-piperazine at 90 K

Synthesis and crystal structures of 1-benzoyl-4-(4-nitro-phen-yl)piperazine, C17H17N3O3, (I) and 1-(4-bromo-benzo-yl)-4-phenyl-piperazine, C17H17BrN2O, (II) are described. Compounds I and II crystallize in the ortho-rhom-bic and monoclinic crystal systems with space groups Pna21 (Z' = 2, I) and P21 (Z' = 1, II), respectively. The crystal of II was a two-component aggregate, treated as a 'twin' for data-acquisition purposes. There are no conventional hydrogen bonds in either I or II, but there are weaker C-H⋯O contacts. Each mol-ecule consists of a central piperazine ring in a chair conformation, with either benzoyl and nitro-phenyl (I) or 4-bromo-benzoyl and phenyl (II) groups attached to different nitro-gen atoms of the piperazine. The various atom-atom contact coverages as qu-anti-fied by Hirshfeld surface analysis fingerprint plots are given.

Crystal-structure studies of 4-phenyl-piperazin-1-ium 4-eth-oxy-benzoate monohydrate, 4-phenyl-piperazin-1-ium 4-meth-oxy-benzoate monohydrate, 4-phenyl-piperazin-1-ium 4-methyl-benzoate monohydrate and 4-phenyl-piperazin-1-ium tri-fluoro-acetate 0.12-hydrate

In this study, four new piperazinium salts, namely, 4-phenyl-piperazin-1-ium 4-eth-oxy-benzoate monohydrate, C9H9O3·C10H15N2·H2O (I); 4-phenyl-piperazin-1-ium 4-meth-oxy-benzoate monohydrate, C10H15N2·C8H7O3·H2O (II); 4-phenyl-piperazin-1-ium 4-methyl-benzoate monohydrate, C10H15N2·C8H7O2·H2O (III); and 4-phenyl-piperazin-1-ium tri-fluoro-acetate 0.12 hydrate, C10H15N2·C2F3O2·0.12H2O (IV), have been synthesized. The single-crystal structures of these compounds reveal that all of them crystallize in the triclinic P space group and the crystal packing of (I)-(III) is built up of ribbons formed by a combination of hydrogen bonds of type N-H⋯O, O-H⋯O and other weak inter-actions of type C-H⋯O and C-H⋯π, leading to a three-dimensional network. In the crystal of (IV), the cations and the anions are connected by C-H⋯O, N-H⋯O and C-H⋯F hydrogen bonds and by C-H⋯π inter-actions, forming sheets which in turn inter-act to maintain the crystal structure by linking through the oxygen atoms of water mol-ecules and van der Waals inter-actions, giving the whole structure.

4-Phenyl-piperazin-1-ium dihydrogen phosphate

The title compound, C₁₀H₁₅N₂⁺·H₂PO₄⁻, is built up from 4-phenyl­piperazin-1-ium cations and dihydrogen phosphate anions. The inter­connection between two adjacent anions is assured by two strong O—H⋯O hydrogen bonds, which lead to the formation of infinite wave-like chains which spread along the a axis. The organic cations connect these chains via N—H⋯O hydrogen bonds. The crystal cohesion and stability are ensured by electrostatic and van der Waals inter­actions which, together with N—H⋯O and O—H⋯O hydrogen bonds, build up a two-dimensional network.

Neutral sulfate berberine modulates cytokine secretion and increases survival in endotoxemic mice

AIM

Berberine is thought to be an immunomodulator, so the present study aimed to investigate the effect of berberine on mortality, lung and intestine injury in endotoxemic mice, and the mechanism of its action.

METHODS

Mice were challenged with lipopolysaccharide (LPS, 28 mg/kg, ip), and neutral sulfate berberine was administrated intragastrically. Mortality was monitored every 12 h, and histology of the lungs and intestine as well as the plasma tumor necrosis factor-alpha (TNF-alpha), interferon- gamma (IFN-gamma), interleukin-12 (IL-12), IL-10, and nitric oxide (NO) levels were examined.

RESULTS

Pretreatment with 50 mg/kg neutral sulfate berberine once a day for 5 days significantly decreased the mortality rate and attenuated tissue injury of the lungs and small intestine in mice challenged with LPS. LPS stimulated a marked increase in plasma levels of TNF-alpha, IFN- gamma, IL-12, IL-10, and NO. The administration of berberine significantly reduced plasma TNF-alpha, IFN- gamma, and NO levels, but did not suppress plasma IL-12 levels in mice exposed to LPS. Furthermore, pretreatment with neutral sulfate berberine augmented IL-10 secretion stimulated by LPS in mice.

CONCLUSION

Pretreatment with neutral sulfate berberine attenuates tissue injury and improves survival in endotoxemic mice, which may be mediated, at least in part, by the inhibition of pro-inflammatory mediator production and upregulation of IL-10 release. These findings might provide a new strategy for the treatment of endotoxemia.

Monitor: molecules and profiles

Monitor provides an insight into the latest developments in drug discovery through brief synopses of recent presentations and publications together with expert commentaries on the latest technologies. There are two sections: Molecules summarizes the chemistry and the pharmacological significance and biological relevance of new molecules reported in the literature and on the conference scene; Profiles offers commentary on promising lines of research, emerging molecular targets, novel technology, advances in synthetic and separation techniques and legislative issues.

Novel DMARDs on the basis of a new concept of dual cytokine regulation, TNF-alpha suppression and IL-10 augmentation

A series of arylpiperazine derivatives was synthesized to obtain agents showing apparent therapeutic effects in a chronic inflammatory animal model, starting from a lead possessing potent dual cytokine regulatory activity in vivo. We found a pyrimidylpiperazine derivative 17c showing the dual regulatory activity and an excellent therapeutic effect in an adjuvant-induced arthritis model.